BioMarin Pharmaceutical Inc.
NasdaqGS:BMRN
$ 84.76
+ $0.05 (0.06%)
$ 84.76
+ $0.05 (0.06%)
Real-time: 03/20/2024 15:59

BMRN - BioMarin Pharmaceutical Stock Prediction 2025 - 2030

20 years of reliable BioMarin Pharmaceutical stock forecast. The Wall Street analysts predict Outperform for BMRN. See at a glance whether NasdaqGS:BMRN will rise in the future.

$134.04
Forecast 2023
$474.28
Forecast 2025
$721.73
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2023
$134.04
Forecast 2025
$474.28
Forecast 2030
$721.73
TopGraphs Quality Ranking
Neutral

Company Info

P/E
0.00
Beta
0.31
Price-to-book Ratio
3.28
Market Cap
16.23B
TEV
17.17 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
128.20%
Forecast 2Y
203.03%
Analyst Price Target
$111.56

BioMarin Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

BioMarin Pharmaceutical Stock Forecast 2023

$108.70

In the last five quarters, BioMarin Pharmaceutical’s Price Target has fallen from $115.93 to $111.56 - a -3.77% decrease. Eighteen analysts predict that BioMarin Pharmaceutical’s share price will fall in the coming year, reaching $108.70. This would represent a decrease of -2.56%.

26.4%
26.4
Last update: 03/12/2024

Highest Price Target $140.00

Average Price Target $108.70

Lowest Price Target $80.00

BioMarin Pharmaceutical Stock Predictions 2025

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jan 2025.

In January 2025, analysts believe the stock price will be $374.45. An increase of 335.41% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Feb 2025.

In February 2025, analysts believe the stock price will be $383.53. An increase of 345.96% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Mar 2025.

In March 2025, analysts believe the stock price will be $392.60. An increase of 356.51% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Apr 2025.

In April 2025, analysts believe the stock price will be $401.68. An increase of 367.07% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in May 2025.

In May 2025, analysts believe the stock price will be $410.75. An increase of 377.62% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jun 2025.

In June 2025, analysts believe the stock price will be $419.83. An increase of 388.17% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jul 2025.

In July 2025, analysts believe the stock price will be $428.90. An increase of 398.72% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Aug 2025.

In August 2025, analysts believe the stock price will be $437.98. An increase of 409.28% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Sep 2025.

In September 2025, analysts believe the stock price will be $447.05. An increase of 419.83% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Oct 2025.

In October 2025, analysts believe the stock price will be $456.13. An increase of 430.38% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Nov 2025.

In November 2025, analysts believe the stock price will be $465.20. An increase of 440.93% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Dec 2025.

In December 2025, analysts believe the stock price will be $474.28. An increase of 451.49% compared to the previous month's estimate.

BioMarin Pharmaceutical Stock Prediction 2030

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jan 2030.

In Jan 2030 analysts predict a share price of $706.37. An increase of 721.36% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Feb 2030.

In Feb 2030 analysts predict a share price of $707.77. An increase of 722.98% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Mar 2030.

In Mar 2030 analysts predict a share price of $709.16. An increase of 724.61% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Apr 2030.

In Apr 2030 analysts predict a share price of $710.56. An increase of 726.23% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in May 2030.

In May 2030 analysts predict a share price of $711.95. An increase of 727.85% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jun 2030.

In Jun 2030 analysts predict a share price of $713.35. An increase of 729.48% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jul 2030.

In Jul 2030 analysts predict a share price of $714.75. An increase of 731.1% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Aug 2030.

In Aug 2030 analysts predict a share price of $716.14. An increase of 732.72% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Sep 2030.

In Sep 2030 analysts predict a share price of $717.54. An increase of 734.35% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Oct 2030.

In Oct 2030 analysts predict a share price of $718.94. An increase of 735.97% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Nov 2030.

In Nov 2030 analysts predict a share price of $720.33. An increase of 737.6% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Dec 2030.

In Dec 2030 analysts predict a share price of $721.73. An increase of 739.22% compared to today's share price.

P/E
0.00
Beta
0.31
Price-to-book Ratio
3.28
Market Cap
16.23B
TEV
17.17 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
128.20%
Forecast 2Y
203.03%
Analyst Price Target
$111.56

BioMarin Pharmaceutical Analyst Ratings Frequently Asked Questions

Who are the analysts watching BioMarin Pharmaceutical Inc.?

The following analysts have recently covered BioMarin Pharmaceutical:

Baird
Barclays
BofA Global Research
Canaccord Genuity
CFRA Equity Research
Citigroup Inc
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Oppenheimer & Co. Inc.
Piper Sandler Companies
RBC Capital Markets
Stifel
Truist Securities
Wedbush Securities Inc.
William Blair & Company L.L.C.
Cantor Fitzgerald & Co.
Baptista Research
BMO Capital Markets Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc. Research
Equisights
Leerink Partners LLC
Raymond James & Associates
Sanford C. Bernstein & Co., LLC
Scotiabank Global Banking and Market
TD Cowen
UBS Investment Bank
Wells Fargo Securities, LLC
(This information refers to the last 90 days.)

Who are the sell-side analysts watching BioMarin Pharmaceutical Inc.?

The following sell-side analysts have recently covered BioMarin Pharmaceutical:

Wang, Huidong
Meacham, Geoffrey Christopher
Bansal, Mohit
Nadeau, Philip M.
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Tewari, Akash
Paraskevopoulos, Michail
Andersen, Karen
Gershell, Leland James
Raymond, Christopher Joseph
Matteis, Paul Andrew
Schwartz, Joseph Patrick
Karnauskas, Robyn Kay Shelton
Lugo, Timothy Francis
Issi, Luca
Argyrides, Andreas
Brayer, Olivia Simone
Majumdar, Ishan
Fye, Jessica Macomber
Biliouris, Konstantinos
Ijem, Whitney Glad
Hardy, Sel
Brill Bongero, Danielle Catherine
Lebowitz, David Neil
Talsania, Parth
Clark-Gartner, Gavin
Purohit, Vikram
Pickering, William
Farmer, George
Merle, Eliana Rachel
Allen, Jack Kilgannon
(This information refers to the last 90 days.)